Literature for peptidase S01.087: TMPRSS13 peptidase

(Topics flags: R Splicing, K Knockout, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2025
1. Joushomme,A., Desilets,A., Champagne,W., Hassanzadeh,M., Lemieux,G., Gravel-Trudeau,A., Lepage,M., Lafreniere,S., Froehlich,U., List,K., Boudreault,P.L. and Leduc,R.
   Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
   J Enzyme Inhib Med Chem40, 2466841-2466841. PubMed  Europe PubMed DOI  I
2024
2. Jin,Z., Zhang,Y., Chen,W., Li,H., Shi,L., Wang,D., Zhu,R. and Zhang,C.
   Intracellular autoactivation and surface location of hepsin, TMPRSS2, and TMPRSS13
   Life Sci123299-123299. PubMed  Europe PubMed DOI
2022
3. Martin,C.E., Murray,A.S., Mackinder,J.R., Sala-Hamrick,K.E., Flynn,M.G., Lundgren,J.G., Varela,F.A. and List,K.
   TMPRSS13 zymogen activation, surface localization, and shedding is regulated by proteolytic cleavage within the non-catalytic stem region
   Biol Chem403, 969-982. PubMed  Europe PubMed DOI
2021
4. Martin,C.E., Murray,A.S., Sala-Hamrick,K.E., Mackinder,J.R., Harrison,E.C., Lundgren,J.G., Varela,F.A. and List,K.
   Posttranslational modifications of serine protease TMPRSS13 regulate zymogen activation, proteolytic activity, and cell surface localization
   J Biol Chem297, 101227-101227. PubMed  Europe PubMed DOI
2020
5. Murray,A.S., Hyland,T.E., Sala-Hamrick,K.E., Mackinder,J.R., Martin,C.E., Tanabe,L.M., Varela,F.A. and List,K.
   The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy
   Oncogene PubMed  Europe PubMed DOI  K
2014
6. Madsen,D.H., Szabo,R., Molinolo,A.A. and Bugge,T.H.
   TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition
   Biochem J461, 487-495. PubMed  Europe PubMed DOI  K
7. Zmora,P., Blazejewska,P., Moldenhauer,A.S., Welsch,K., Nehlmeier,I., Wu,Q., Schneider,H., Pohlmann,S. and Bertram,S.
   DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry
   J Virol88, 12087-12097. PubMed  Europe PubMed DOI
2011
8. Antalis,T.M., Bugge,T.H. and Wu,Q.
   Membrane-anchored serine proteases in health and disease
   Prog Mol Biol Transl Sci99, 1-50. PubMed  Europe PubMed DOI  V
2010
9. Hashimoto,T., Kato,M., Shimomura,T. and Kitamura,N.
   TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor
   FEBS J277, 4888-4900. PubMed  Europe PubMed DOI
10. Okumura,Y., Takahashi,E., Yano,M., Ohuchi,M., Daidoji,T., Nakaya,T., Bottcher,E., Garten,W., Klenk,H.D. and Kido,H.
    Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication
    J Virol84, 5089-5096. PubMed  Europe PubMed DOI  R
2008
11. Kido,H. and Okumura,Y.
    Mspl/Tmprss13
    Front Biosci13, 754-758. PubMed  Europe PubMed DOI  V
2003
12. Szabo,R., Wu,Q., Dickson,R.B., Netzel-Arnett,S., Antalis,T.M. and Bugge,T.H.
    Type II transmembrane serine proteases
    Thromb Haemost90, 185-193. PubMed  Europe PubMed DOI  V
2001
13. [YEAR:19-3-2001]Kim,D.R., Sharmin,S., Inoue,M. and Kido,H.
    Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung
    Biochim Biophys Acta1518, 204-209. PubMed  Europe PubMed DOI